Clinical Trial Update: Chronic CED of TPT for Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating chronic convection-enhanced delivery of TPT for recurrent malignant glioma is currently recruiting. The study lists brain tumor and mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Glioma

Drugs mentioned

• TPT (topotecan)

Snippet

Sponsor: Jeffrey N. Bruce | Conditions: Brain Tumor, Recurrent, Malignant Glioma (WHO Grade III or IV) | Phase 1 | Status: RECRUITING